• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Atopic dermatitis tops ‘Most Conducted Trials’ list

The largest number of dermatologic clinical trials over the past decade - 72 - were conducted for treatments for atopic dermatitis, according to recently released statistics gathered by a London-based market-research firm.

London - The largest number of dermatologic clinical trials over the past decade - 72 - were conducted for treatments for atopic dermatitis, according to recently released statistics gathered by a London-based market-research firm.

According to Companies & Markets’ “Clinical Trial Recruitment in Dermatology,” the conditions that prompted the second-, third- and fourth-highest number of trials were acne vulgaris (40), herpes zoster (28) and candidiasis (20), respectively.

The total number of dermatology trials from 2000 to 2010 was 163. The total number of patients recruited for clinical trials on acne vulgaris was 21,715, while atopic dermatitis trials recruited 11,371 patients, herpes zoster trials recruited 8,022 and candidiasis trials recruited 4,233, according to the report.

Live-pr.com reports that “Clinical Trial Recruitment in Dermatology” analyzes a number of clinical trials conducted for major indications; provides information about the total number of clinical trials conducted by phase, geography, major sponsors and clinical trials per year; and analyzes the total number of patients recruited by phase of clinical trial, geography and major sponsors. Also included is an analysis of the average number of patients recruited per trial per year for various indications.

Go back to the Dermatology Times eNews newsletter.

Related Videos
3 experts are featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
2 experts in this video
2 experts in this video
2 experts in this video
3 experts in this video
3 experts in this video
© 2024 MJH Life Sciences

All rights reserved.